Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | +2.01% |
|
+13.97% | +85.45% |
Jun. 13 | Xilio Therapeutics, Inc. Announces Board Appointments | CI |
May. 14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+85.45% | 36.91M | |
+22.10% | 47.07B | |
+46.45% | 42.06B | |
-3.12% | 39.98B | |
+36.10% | 33.02B | |
-6.30% | 27.9B | |
+18.71% | 27.63B | |
+46.15% | 14.37B | |
+44.52% | 13.45B | |
+0.19% | 12.03B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Raymond James Starts Xilio Therapeutics at Outperform With $31 Price Target